Clinical Trial of Efepoetin Alfa in Healthy Subjects
Clinical trial NCT06490939 · COMPLETED
Trial details
- NCT number
- NCT06490939
- Sponsor
- Genexine, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-29
- Primary completion
- 2025-03-25
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.